The derivatives of pyrimidin-4-one can adopt either a 1H-or a 3H-tautomeric form, which affects the hydrogen-bonding interactions in cocrystals with compounds containing complementary functional groups. In order to study their tautomeric preferences, we crystallized 2,6-diaminopyrimidin-4-one and 2-amino-6-methylpyrimidin-4-one. During various crystallization attempts, four structures of 2,6-diaminopyrimidin-4-one were obtained, namely solvent-free 2,6-diaminopyrimidin-4-one, C 4 H 6 N 4 O, (I), 2,6-diaminopyrimidin-4-one-dimethylformamide-water (3/4/1), C 4 H 6 N 4 OÁ1.33C 3 H 7 NOÁ0.33H 2 O, (Ia), 2,6-diaminopyrimidin-4-one dimethylacetamide monosolvate, C 4 H 6 N 4 OÁC 4 H 9 NO, (Ib), and 2,6-diaminopyrimidin-4-one-N-methylpyrrolidin-2-one (3/2), C 4 H 6 N 4 OÁ1.5C 5 H 9 NO, (Ic). The 2,6-diaminopyrimidin-4-one molecules exist only as 3H-tautomers. They form ribbons characterized by R 2 2 (8) hydrogen-bonding interactions, which are further connected to form three-dimensional networks. An intermolecular N-HÁ Á ÁN interaction between amine groups is observed only in (I). This might be the reason for the pyramidalization of the amine group. Crystallization experiments on 2-amino-6-methylpyrimidin-4-one yielded two isostructural pseudopolymorphs, namely 2-amino-6-methylpyrimidin-4(3H)-one-2-amino-6-methylpyrimidin-4(1H)-one-dimethylacetamide (1/1/1), C 5 H 7 N 3 OÁC 5 H 7 N 3 OÁC 4 H 9 NO, (IIa), and 2-amino-6-methylpyrimidin-4(3H)-one-2-amino-6-methylpyrimidin-4(1H)-one-N-methylpyrrolidin-2-one (1/1/1), C 5 H 7 N 3 OÁC 5 H 7 N 3 OÁC 5 H 9 -NO, (IIb). In both structures, a 1:1 mixture of 1H-and 3H-tautomers is present, which are linked by three hydrogen bonds similar to a Watson-Crick C-G base pair.
Comment
Pyrimidin-4-one derivatives are of particular interest in pharmacology and molecular biology. They include nucleobases and many important pharmaceutical drugs, e.g. antiinflammatory (Kawade et al., 2011) , anticancer (Lu et al., 2007) , antihistaminic and bronchorelaxant agents (Youssouf et al., 2008) . Pyrimidin-4-one can exist in three tautomeric forms: as a 1H-or 3H-tautomer or as a hydroxypyrimidine. An NMR study revealed that the preference of each tautomeric form depends on its state, although no hydroxypyrimidine form has ever been observed. In the solid state, only the 3H-tautomer has been found, while in polar solvents, a mixture of 1H-and 3H-tautomers is observed (Ló pez et al., 2000) . These results agree with the two crystal structures containing pyrimidin-4-one in the Cambridge Structural Database (CSD, Version 5.31 of November 2009, plus four updates; Allen, 2002) , which confirmed that the 3H-tautomer is preferred [CSD refcodes BAGQUV (Vaillancourt et al., 1998) and XOLHOW (Bhogala et al., 2008) ].
We are interested in the hydrogen-bonding interaction between pyrimidin-4-one derivatives and compounds containing complementary functional groups. Since the occurrence of tautomers results in different synthon combinations (Bhogala et al., 2008) , we crystallized 2,6-diaminopyrimidin-4-one and 2-amino-6-methylpyrimidin-4-one to study their tautomeric preferences. Four structures of 2,6-diaminopyrimidin-4-one were obtained during various crystallization experiments, namely solvent-free 2,6-diaminopyrimidin-4-one, (I), a dimethylformamide-water solvate (3/4/1), (Ia), a dimethylacetamide monosolvate, (Ib), and an N-methylpyrrolidin-2-one (3/2) solvate, (Ic). Another N-methylpyrrolidin-2-one solvate of minor crystal quality was also obtained (Gerhardt et al., 2011) . All 2,6-diaminopyrimidin-4-one molecules exist as 3H-tautomers. Crystallization attempts on 2-amino-6-methylpyrimidin-4-one yielded two pseudopolymorphs, namely dimethylacetamide monosolvate, (IIa), and N-methylpyrrolidin-2-one monosolvate, (IIb). In both structures, a 1:1 mixture of 1H-and 3H-tautomers is present.
2,6-Diaminopyrimidin-4-one, (I), crystallizes in the monoclinic space group P2 1 /c with one molecule in the asymmetric unit (Fig. 1) . One amine group is planar and twisted slightly out of the plane of the ring, while the other is pyramidalized and shows a longer C-NH 2 bond [sums of the C-N-H and H-N-H angles at the N atoms = 359.1 (at N21) and 347.3 (at N61); C-NH 2 = 1.337 (2) (at N21) and 1.365 (2) Å (at N61)]. The 2,6-diaminopyrimidin-4-one molecules form ribbons characterized by three hydrogen bonds, consisting of one R 2 2 (8) interaction (Bernstein et al., 1995) with N-HÁ Á ÁO and N-HÁ Á ÁN hydrogen bonds, and another R 2 2 (8) interaction with two N-HÁ Á ÁN hydrogen bonds (Fig. 2) . This arrangement is similar to that in the cytosine-guanine base pair. The ribbons are rippled and further connected into layers by R 3 4 (12) interactions. Other N-HÁ Á ÁO hydrogen bonds stabilize the layers to form a three-dimensional network.
Compound (Ia) formed during crystallization attempts from dimethylformamide (DMF). It crystallizes in the monoclinic space group P2 1 with three planar 2,6-diaminopyrimidin-4-one molecules (r.m.s deviations = 0.008, 0.012 and 0.013 Å for all non-H atoms) and four DMF molecules. Since we used nonwater-free solvent, one water molecule is also present in the asymmetric unit (Fig. 3) . The three 2,6-diaminopyrimidin-4-one molecules show different hydrogen-bond arrangements. Molecules A and B are connected by either R (Fig. 4) . The ribbons are further stabilized by hydrogen bonds to the solvent molecules. One DMF molecule is N-HÁ Á ÁO hydrogen bonded only to molecule A, while another DMF molecule links molecules A and B by two N-HÁ Á ÁO hydrogen bonds. Furthermore, chains running along the a axis consisting of N-HÁ Á ÁO hydrogen-bonded molecules C are observed ( C is disordered over two sites with a planar arrangement (r.m.s deviation = 0.011 Å ). The packing of (Ia) shows ribbons and chains, which are connected by N-HÁ Á ÁO hydrogen bonds to form a three-dimensional network. The water molecule forms hydrogen bonds bridging the three 2,6-diaminopyrimidin-4-one molecules and thus additionally stabilizes the structure.
The dimethylacetamide (DMAC) monosolvate, (Ib), crystallizes in the monoclinic space group Cc with two 2,6-diaminopyrimidin-4-one (r.m.s deviations = 0.013 and 0.025 Å for all non-H atoms) and two DMAC molecules in the asymmetric unit (Fig. 6 ). In the packing of (Ib), ribbons consisting of 2,6-diaminopyrimidin-4-one molecules run in two different directions [parallel to (111) and (111)]. Similar to (Ia), the molecules are stabilized either by N-HÁ Á ÁO or by N-HÁ Á ÁN hydrogen bonds with an R 2 2 (8) pattern (Fig. 7) . These ribbons are further N-HÁ Á ÁO hydrogen bonded to form channels, in which solvent molecules are located (Fig. 8) . One DMAC molecule is coplanar with the 2,6-diaminopyrimidin-4-one molecules and shows only van der Waals interactions, while the O atom of the other DMAC molecule is threefold N-HÁ Á ÁO hydrogen bonded to 2,6-diaminopyrimidin-4-one molecules.
Compound (Ic) crystallizes as an N-methylpyrrolidin-2-one (NMP) solvate with two 2,6-diaminopyrimidin-4-one and three solvent molecules in the asymmetric unit (Fig. 9) . The 2,6-diaminopyrimidin-4-one molecules are planar (r.m.s deviations = 0.005 and 0.012 Å for all non-H atoms). R are additionally stabilized by N-HÁ Á ÁO bonds between molecule A and one NMP molecule (Fig. 10) . In contrast, molecules B form dimers stabilized by R 2 2 (8) N-HÁ Á ÁN hydrogen bonds. Two NMP molecules are N-HÁ Á ÁO hydrogen bonded to each molecule B, and thus inversionsymmetric arrangements of two molecules B and two NMP molecules are formed (Fig. 11) . These link the ribbons to form a three-dimensional network.
The two isostructural 2-amino-6-methylpyrimidin-4-one solvates, (IIa) and (IIb), crystallize in the triclinic space group P1 with similar lattice parameters. A 1:1 ratio of 1H-and 3H-tautomers is present in both crystal structures. The asymmetric unit of (IIa) consists of the two tautomers and one DMAC molecule (Fig. 12) , while (IIb) crystallizes with the two tautomers and one disordered NMP molecule (Fig. 13) . In both structures, the molecules are coplanar with each other, and both the hydrogen-bonding interactions and the crystal packings are similar (Figs. 14 and 15). The two tautomers are linked by two R A perspective view of (Ic), showing the atom-numbering scheme. Displacement ellipsoids are drawn at the 50% probability level. Dashed lines indicate hydrogen bonds. In order to study the preference of the 1H-and 3H-tautomeric forms, a CSD substructure search for pyrimidin-4-one derivatives was undertaken. 15 entries for the 1H form, 39 entries for the 3H form and five entries with both tautomeric forms were found [refcodes ICYTIN (Sharma & McConnell, 1965) , ICYTIN01 (Portalone & Colapietro, 2007) , LEJLAN and LEJLOB (Bannister et al., 1994) , and ZERMIS (Toledo et al., 1995) ]. Examining only entries containing 2,6-diaminopyrimidin-4-one, no 1H-tautomer has been reported [refcodes SEYDIJ (Skoweranda et al., 1990) and GIMZUY (Subashini et al., 2007) ]. The preference for the 3H-tautomeric form is also shown in two recently reported polymorphs of the monohydrate (Suleiman Gwaram et al., 2011) , in the NMP solvate with minor crystal quality (Gerhardt et al., 2011) and in the four crystal structures above, viz. (I) and (Ia)-(Ic). A possible explanation for the absence of the 1H-tautomeric form might be the repulsion of the H atoms from the three amino groups presenting an adjacent donor-donor-donor hydrogen-bonding site. In contrast, 2-amino-6-methylpyrimidin-4-one exists in both 1H-and 3H-tautomeric forms. In the solvent-free P2 1 /n structure it exists as a 1H-tautomer (refcode FETSEC; Lowe et al., 1987) , while in the solvent-free C2/c polymorph, both 1H-and 3H-tautomers are shown as a result of disordered H atoms (refcode ZERMIS; Toledo et al., 1995) . The 3H-tautomeric form is observed in its cocrystals with glutaric acid and adipic acid (refcodes ZUKXAE and ZUKXEI; Liao et al., 1996) . Interestingly, only in the solvates (IIa) and (IIb) do both tautomers exist in a 1:1 ratio.
Almost all 2,6-diaminopyrimidin-4-one and 2-amino-6-methylpyrimidin-4-one molecules are planar. The pyramidalization of one amine group in (I) is also observed in the (2) , respectively].
Comparing the hydrogen-bond arrangements formed by the 2,6-diaminopyrimidin-4-one molecules, ribbons characterized by R 2 2 (8) interactions involving either two N-HÁ Á ÁO or two N-HÁ Á ÁN bonds are observed in all structures. However, an intermolecular N-HÁ Á ÁN interaction between the amine groups is only observed in (I) and in the orthorhombic polymorph (form I), which may explain the pyramidalization of one amine group in these two structures. The crystal packings in the various structures show three-dimensional networks additionally stabilized by solvent molecules. The 1H-and 3H-tautomers of 2-amino-6-methylpyrimidin-4-one are linked by three hydrogen bonds, similar to what is observed in the Watson-Crick C-G base pair. Identical arrangements are observed in the five CSD entries for pyrimidin-4-one derivatives containing both tautomeric forms. Altogether, (I) and (Ia)-(Ic) confirm the 3H-tautomer preference of 2,6-diaminopyrimidin-4-one, while there is no preference for 2-amino-6-methylpyrimidin-4-one. It can exist as a 1H-or 3H-tautomer, or as a 1:1 mixture of both tautomers, as shown in the crystal structures of (IIa) and (IIb).
Experimental
Solvent evaporation experiments with commercially available 2,6-diaminopyrimidin-4-one under different conditions yielded (I) and (Ia)-(Ic) ( Table 7) . Single crystals of (IIa) and (IIb) were obtained by crystallization of commercially available 2-amino-6-methylpyrimidin-4-one (Table 8) . None of the solvents used in the experiments was water-free.
Compound (I)
Crystal data Table 2 Hydrogen-bond geometry (Å , ) for (Ia). 
Table 1
Hydrogen-bond geometry (Å , ) for (I). Table 3 Hydrogen-bond geometry (Å , ) for (Ib). Table 4 Hydrogen-bond geometry (Å , ) for (Ic). Symmetry codes: (i) Àx; Ày þ 2; Àz þ 1; (ii) Àx þ 1; Ày þ 1; Àz þ 1; (iii) Àx þ 2, Ày þ 1; Àz. Table 5 Hydrogen-bond geometry (Å , ) for (IIa). Table 6 Hydrogen-bond geometry (Å , ) for (IIb). 
À3
The H atoms, except those bonded to disordered solvent atoms and to solvent water, were initially located by difference Fourier synthesis. Subsequently, H atoms bonded to C atoms were refined using a riding model, with methyl C-H = 0.98 Å , secondary C-H = 0.99 Å and aromatic C-H = 0.95 Å , and with U iso (H) = 1.5U eq (C) for methyl or 1.2U eq (C) for secondary and aromatic H atoms. In (I), H atoms bonded to N atoms were refined isotropically, while in the other structures, they were refined using a riding model, with amide and terminal N-H = 0.88 Å and with U iso (H) = 1.2U eq (N). For the water molecule in (Ia), the following restraints were applied during refinement: O-H = 0.84 (1) Å and HÁ Á ÁH = 1.40 (1) Å , with U iso (H) = 1.2U eq (O). Similarity restraints were applied for the 1,2 and 1,3 distances of both DMAC molecules in (Ib), and for the minor occupied orientation of the NMP molecule in (IIb).
In (Ia), all C atoms of one DMF molecule are disordered over two positions, with a site-occupation factor of 0.67 (1) for the major occupied orientation. In (IIb), the NMP molecule is disordered over a pseudo-mirror plane along atoms O2X and C5Y. The site-occupation factor for the major occupied orientation is 0.78 (1). The disordered atoms in (Ia) and (IIb) were refined isotropically.
The E-value distribution of (Ib) could not be used as a hint for or against a centrosymmetric space group (mean value of |E 2 À 1| = 0.874). A refinement attempt for (Ib) in the centrosymmetric space group C2/c showed difference electron densities higher than 0.50 e Å À3 within the nonsolvent molecule, and both solvent molecules are highly disordered. In spite of a possible higher symmetry, tested by ADDSYM (Le Page, 1987 Page, , 1988 Spek, 2009 ), (Ib) was refined in the noncentrosymmetric space group Cc, which led to ordered solvent molecules. For (Ia) and (Ib), Friedel pairs were merged prior to refinement, due to the absence of anomalous scatterers. The absolute structure was arbitrarily assigned.
For all compounds, data collection: X-AREA (Stoe & Cie, 2001 ); cell refinement: X-AREA; data reduction: X-AREA; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: Mercury (Version 2.2; Macrae et al., 2008) and XP (Sheldrick, 2008) ; software used to prepare material for publication: publCIF (Westrip, 2010) . Table 7 Crystallization of 2,6-diaminopyrimidin-4-one. Table 8 Crystallization of 2-amino-6-methylpyrimidin-4-one. 
